Clinical Trial Update: Cathepsin Activatable Fluorescent Probe [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a cathepsin-activatable fluorescent probe for imaging in soft tissue sarcoma and breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Soft Tissue Sarcoma

Snippet

Sponsor: David Kirsch | Conditions: Sarcoma, Soft Tissue Sarcoma | Phase 1 | Status: COMPLETED